Synthesis and evaluation of spirobenzazepines as potent vasopressin receptor antagonists
- 7 June 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (11) , 2987-2989
- https://doi.org/10.1016/j.bmcl.2004.02.103
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Synthesis and biological evaluation of novel indoloazepine derivatives as non-peptide vasopressin V2 receptor antagonistsBioorganic & Medicinal Chemistry Letters, 2003
- Development and therapeutic indications of orally-active non-peptide vasopressin receptor antagonistsExpert Opinion on Investigational Drugs, 2001
- The synthesis and vasopressin (AVP) antagonist activity of a novel series of n -aroyl-2,4,5,6-tetrahydropyrazolo [3,4- d ]thieno[3,2- b ]azepinesBioorganic & Medicinal Chemistry Letters, 2000
- Conivaptan HydrochlorideDrugs of the Future, 2000
- 5-Fluoro-2-methyl-N-[4-(5H-pyrrolo[2,1-c]- [1,4]benzodiazepin-10(11H)-ylcarbonyl)-3- chlorophenyl]benzamide (VPA-985): An Orally Active Arginine Vasopressin Antagonist with Selectivity for V2ReceptorsJournal of Medicinal Chemistry, 1998
- Orally Active, Nonpeptide Vasopressin V2 Receptor Antagonists: A Novel Series of 1-[4-(Benzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepines and Related CompoundsJournal of Medicinal Chemistry, 1996
- OPC-31260Drugs of the Future, 1993
- Signal transduction of V1-vascular vasopressin receptorsRegulatory Peptides, 1992
- Preparation and rearrangement of 2-allyloxyethyl aryl sulfoxides; a mercury-free claisen sequenceTetrahedron Letters, 1990
- Hormonal Stimulation of Phosphatidylinositol Breakdown, with Particular Reference to the Hepatic Effects of VasopressinBiochemical Society Transactions, 1979